Imiquimod: A Off-Label Drug in the Management of Oral Homogeneous Leukoplakia: A Pilot Study
Background: Imiquimod (IMQ) is an immunomodulatory agent that possesses antitumor and antiviral activity with its proven effect on cancerous and precancerous lesions. It serves as a noninvasive treatment option for leukoplakia. Objective: To determine the effectiveness of 5% Topical IMQ in patients...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Серія: | Journal of Indian Academy of Oral Medicine and Radiology |
| Предмети: | |
| Онлайн доступ: | https://journals.lww.com/10.4103/jiaomr.jiaomr_133_25 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|